Invasive breast carcinoma – Diagnostics

Go back

Finding out you have invasive breast carcinoma can feel overwhelming, but understanding what tests and checks you may need can help you feel more prepared and in control during this difficult time.

Introduction: Who Should Undergo Diagnostic Tests and When

Invasive breast carcinoma is the most common form of breast cancer, accounting for about 70 to 80 percent of all breast cancer cases. Sometimes called invasive ductal carcinoma or IDC, this type of cancer starts in the milk ducts of the breast and then spreads into the surrounding breast tissue. From there, it can potentially travel to other parts of your body through your blood or lymphatic system.[2][9]

You should consider seeking diagnostic tests if you notice any changes in your breasts, even if they seem minor. Many people discover breast cancer through routine screening mammograms before they ever feel any symptoms. This is actually a good thing, because catching cancer early often means better treatment outcomes. However, if your screening mammogram shows something unusual, your doctor will refer you to a breast clinic for further testing.[2][13]

Common warning signs that should prompt you to see your doctor include finding a new lump or thickening in your breast or armpit, noticing changes in the size or shape of your breast, seeing skin changes like puckering or dimpling, experiencing fluid leaking from your nipple when you’re not pregnant or breastfeeding, or observing changes in the position of your nipple. Sometimes invasive breast carcinoma doesn’t form a clear lump at all. Instead, you might just feel an area that seems thicker or harder than the rest of your breast tissue.[2][3]

It’s important to know that most people who go to a breast clinic with symptoms do not end up having breast cancer. Many breast changes are caused by other, less serious conditions. Still, any persistent change deserves medical attention. Don’t wait or hope it will go away on its own.[2][13]

⚠️ Important
Routine breast screening with mammography can often detect cancer before you notice any symptoms at all. Following recommended screening guidelines for your age and risk level gives you the best chance of finding cancer when it’s most treatable. If you’re unsure about when you should start screening, talk to your healthcare provider about what’s right for you.

Women age 55 and older are most commonly affected by invasive breast carcinoma, though it can occur in younger women as well. About 10 percent of women diagnosed with this type of breast cancer are under age 45. Men can also develop invasive breast carcinoma, though it’s much less common. In fact, about 98 percent of male breast cancers are invasive ductal carcinoma.[4][8]

Standard Diagnostic Methods

When you visit a breast clinic, either because you found something worrying or because your screening mammogram showed an abnormal area, you’ll typically undergo several tests. Your doctor needs these tests to determine whether cancer is present, and if it is, what type it is and how far it has spread. The good news is that modern diagnostic tools are quite sophisticated and can provide detailed information to guide your treatment.[2][13]

Physical Breast Examination

Your doctor will start with a thorough physical examination of your breasts. They’ll carefully feel for any lumps or areas of thickening in your breast tissue. They’ll also check your armpits for swollen lymph nodes, which are small bean-shaped structures that filter fluid and help fight infection. If breast cancer has started to spread, the lymph nodes under your arm are usually the first place it goes.[5][10]

During this examination, your doctor will look at the skin of your breast for any changes like dimpling, redness, or inflammation. They’ll examine your nipples to see if there are any changes in position or appearance. While this physical exam is an important starting point, it cannot definitively diagnose breast cancer. Your doctor will need imaging tests and possibly a tissue sample to know for sure what’s happening.[8]

Mammography

A mammogram is an X-ray picture of your breast. It’s the most common imaging test used to look for breast cancer. During a mammogram, your breast is gently compressed between two plates while images are taken. This compression can be uncomfortable, but it only lasts a few seconds and helps create clearer images.[3]

Mammograms can detect tumors that are too small to feel during a physical exam. They can show abnormal areas, masses, or calcium deposits that might indicate cancer. However, mammography doesn’t catch every breast cancer. Some cancers don’t show up on mammograms, especially in women with dense breast tissue. In fact, probably 10 to 15 percent of cancers that can be felt don’t appear on a mammogram.[12]

Breast Ultrasound

An ultrasound scan uses sound waves to create pictures of the inside of your breast. It’s completely painless and doesn’t use radiation. During the test, a technician will spread gel on your breast and move a small device called a transducer across your skin. This device sends out sound waves that bounce off your breast tissue and create images on a computer screen.[3][13]

Ultrasound is particularly helpful for examining lumps that can be felt but may not show up clearly on a mammogram. It can help determine whether a lump is solid (which might be cancer) or filled with fluid (which is usually a harmless cyst). Ultrasound is often used alongside mammography to get a more complete picture of what’s happening in your breast.[14]

Breast MRI

Magnetic Resonance Imaging, or MRI, uses magnets and radio waves to create detailed pictures of your breast tissue. Unlike mammography, it doesn’t use radiation. An MRI can sometimes detect cancer that doesn’t show up on a mammogram, especially in women with dense breasts.[3]

During a breast MRI, you’ll lie face down on a padded table with openings for your breasts. The table slides into a large tube-shaped machine. The test typically takes 30 to 45 minutes. Some people find the enclosed space uncomfortable, and the machine can be noisy. You may receive a contrast dye through an IV to help certain tissues show up more clearly in the images.[14]

Breast Biopsy

A biopsy is the only way to know for certain whether you have breast cancer. During this procedure, your doctor removes a small sample of breast tissue so it can be examined under a microscope by a specialist called a pathologist. There are several types of breast biopsy, but they all serve the same purpose: to get tissue that can be analyzed in a laboratory.[3][13]

The most common type is a needle biopsy, where your doctor uses a needle to remove tissue from the suspicious area. This is usually done with local anesthesia, so you’re awake but your breast is numbed. Your doctor might use ultrasound or mammography images to guide the needle to exactly the right spot. Sometimes, if the area can’t be felt or seen easily, you might need a more specialized biopsy procedure.[14]

After the biopsy, the tissue sample goes to a laboratory where experts examine it carefully. They’ll determine whether cancer cells are present, and if they are, what type of breast cancer it is. This information is crucial because different types of breast cancer may require different treatments.[15]

Determining Cancer Characteristics

If cancer is found, the laboratory will perform additional tests on your biopsy sample to understand more about your specific cancer. These tests check for certain proteins and receptors on the cancer cells. Your cancer cells will be tested to see if they have receptors for hormones called estrogen and progesterone. These are called hormone receptors. Cancer cells may also be tested for a protein called HER2.[15][16]

Knowing the receptor status of your cancer is extremely important. It tells your doctors whether certain hormones in your body might be helping the cancer grow. It also indicates which treatments are most likely to work for you. For example, if your cancer has estrogen receptors, drugs that block estrogen might be effective. If your cancer makes high levels of HER2 protein, there are targeted drugs designed specifically for that type of cancer.[9][10]

Some breast cancers are called triple-negative because they don’t have estrogen receptors, progesterone receptors, or extra HER2 protein. These cancers can be more challenging to treat because hormone therapy and HER2-targeted drugs won’t work. However, there are still effective treatment options available, including chemotherapy and newer targeted treatments.[9]

Staging Tests

Once invasive breast carcinoma is diagnosed, your doctor needs to determine the stage of your cancer. The stage describes how large the tumor is and whether it has spread beyond the breast. Knowing the stage helps your medical team plan the most appropriate treatment and gives you a better understanding of what to expect.[10]

For staging, you might need additional imaging tests like a chest X-ray, CT scan, bone scan, or PET scan. These tests help doctors see if cancer has spread to your lymph nodes or to other parts of your body like your bones, liver, lungs, or brain. Not everyone needs all these tests. Your doctor will decide which ones are necessary based on your specific situation.[16]

⚠️ Important
Getting a second opinion on your diagnosis or recommended treatment plan is completely appropriate and can give you greater confidence as you move forward. Seeking additional medical insight is your right as a patient, and a good doctor will understand and support your decision to do so. A second opinion may provide new perspectives or alternative treatment options that better suit your needs.

Diagnostic Tests for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or combinations of treatments for breast cancer. These trials are carefully designed to advance medical knowledge and improve care for future patients. If you’re interested in participating in a clinical trial, you’ll need to undergo specific diagnostic tests to determine whether you meet the eligibility criteria.[16]

Each clinical trial has its own set of requirements, called inclusion and exclusion criteria. These criteria ensure that the study includes people who are most likely to benefit from the experimental treatment and whose results will provide meaningful scientific information. The specific tests you need depend on which trial you’re considering, but there are some common categories of testing that many trials require.[15]

Detailed Cancer Characterization

Clinical trials often require very detailed information about your cancer’s characteristics. Beyond the standard hormone receptor and HER2 testing, some trials may require additional molecular or genetic testing of your tumor tissue. This might include looking for specific genetic mutations or testing for other proteins that could affect how your cancer responds to treatment.[16]

Some trials focus on cancers with particular features, such as triple-negative breast cancer or HER2-positive disease. Others might look for specific genetic changes in the cancer cells, like mutations in genes called PIK3CA or BRCA. If a trial is testing a treatment designed to target a specific characteristic, you’ll need testing to confirm your cancer has that feature before you can enroll.[15]

Baseline Health Assessment

Before you can join a clinical trial, researchers need to establish your baseline health status. This typically includes blood tests to check your kidney function, liver function, and blood cell counts. These tests help ensure you’re healthy enough to tolerate the experimental treatment and provide a comparison point for monitoring side effects during the trial.[16]

You may also need imaging scans to measure the size and location of your tumors precisely. These baseline scans will be compared to scans taken later during the trial to see whether the treatment is working. Common imaging tests include CT scans, MRI scans, or PET scans, depending on where your cancer is located.[15]

Functional Status Evaluation

Clinical trials often require that participants have a certain level of physical functioning. This helps ensure that you can handle the demands of the treatment being tested and complete the study requirements. Your doctor will evaluate your ability to care for yourself and perform daily activities. This assessment helps researchers understand how the disease and treatment affect your quality of life.[16]

Genetic Testing for Hereditary Cancer

Some clinical trials specifically study people who have inherited genetic mutations that increase breast cancer risk, such as mutations in the BRCA1 or BRCA2 genes. If you have a family history of breast cancer, especially if relatives developed cancer at young ages, you might be offered genetic counseling and testing. These tests analyze your DNA from a blood sample to look for inherited mutations that could affect your cancer risk or treatment options.[16]

Genetic testing results can influence which clinical trials you’re eligible for, particularly trials testing treatments called PARP inhibitors, which work especially well in cancers associated with BRCA mutations. Understanding your genetic status can also provide important information for your family members about their own cancer risks.[15]

Ongoing Monitoring During Trials

If you do enroll in a clinical trial, you’ll undergo regular diagnostic tests throughout your participation. These repeated tests help researchers track how well the treatment is working and watch for any side effects. You might have blood tests, imaging scans, or other assessments at scheduled intervals. This close monitoring is actually one of the benefits of clinical trial participation—you receive very careful, detailed medical attention throughout your treatment.[16]

The specific schedule of tests varies by trial, but the research team will explain exactly what to expect. They’ll also make sure you understand any results that come back and what they mean for your continued participation in the study. Remember that participating in a clinical trial is voluntary, and you can withdraw at any time if you decide it’s not right for you.[15]

Prognosis and Survival Rate

Prognosis

Your individual outlook after an invasive breast carcinoma diagnosis depends on many factors that are unique to your situation. These factors include the stage of your cancer when it’s found, meaning how large the tumor is and whether it has spread to lymph nodes or other parts of your body. The grade of your cancer, which describes how abnormal the cancer cells look under a microscope, also affects prognosis. Higher-grade cancers tend to grow and spread more quickly.[2][13]

The receptor status of your cancer significantly influences your prognosis. Cancers that have hormone receptors or HER2 protein often respond well to targeted treatments, which can improve outcomes. Triple-negative breast cancers, which lack these receptors, can be more challenging to treat but newer therapies are improving results for these patients as well. Your age, overall health, and how well you respond to treatment all play roles in determining your individual prognosis.[10][15]

Healthcare providers often detect invasive breast carcinoma through screening before symptoms appear. When found early, before the cancer has spread beyond the breast, treatment outcomes tend to be much better. This is why regular screening mammography is so important—it gives you the best chance of finding cancer when it’s most treatable. Even when cancer has spread to nearby lymph nodes or beyond, many effective treatments are available that can control the disease for years.[12]

Survival rate

Survival rates for invasive breast carcinoma have been improving steadily over the past decades thanks to better screening, earlier detection, and more effective treatments. It’s important to understand that survival statistics are estimates based on large groups of people and may not predict exactly what will happen to any individual person. Your own outcome depends on your specific circumstances.[21]

When looking at survival numbers, it’s also worth knowing that the statistics you see today are based on patients who were diagnosed and treated several years ago. Because treatments keep getting better, especially with newer targeted therapies, antibody-drug conjugates, and immunotherapy options, current patients may have even better outcomes than these historical numbers suggest. Many recent advances in treatment weren’t available when the data for today’s survival statistics was collected.[21]

People are now living longer after a metastatic breast cancer diagnosis than ever before, and some report living active, fulfilling lives with advanced disease. Research from 2017 showed more than 150,000 women in the United States were living with metastatic breast cancer. Treatment advances since then have continued to improve outcomes, with new drug classes and combination therapies offering hope for extended survival and quality of life.[18][21]

Ongoing Clinical Trials on Invasive breast carcinoma

  • Study on Indocyanine Green for Evaluating Surgical Margins in Patients Undergoing Breast-Conserving Surgery for Early Invasive Breast Cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    Belgium
  • A study testing zanidatamab combined with chemotherapy before surgery in patients with HER2-positive breast cancer

    Not yet recruiting

    2 1 1 1
    Germany Italy Spain

References

https://www.cancer.org/cancer/types/breast-cancer/about/types-of-breast-cancer/invasive-breast-cancer.html

https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/invasive-breast-cancer

https://breastcancernow.org/about-breast-cancer/diagnosis/types-of-breast-cancer/invasive-breast-cancer-no-special-type

https://www.bcrf.org/about-breast-cancer/invasive-ductal-carcinoma/

https://www.komen.org/breast-cancer/facts-statistics/what-is-breast-cancer/invasive-breast-cancer/

https://www.mdanderson.org/cancerwise/invasive-ductal-carcinoma–6-things-to-know-about-this-common-breast-cancer.h00-159775656.html

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.webmd.com/breast-cancer/invasive-breast-cancer

https://www.cdc.gov/breast-cancer/about/index.html

https://my.clevelandclinic.org/health/diseases/22117-invasive-ductal-carcinoma-idc

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.ncbi.nlm.nih.gov/books/NBK6879/

https://www.cancerresearchuk.org/about-cancer/breast-cancer/types/invasive-breast-cancer

https://www.cedars-sinai.org/health-library/diseases-and-conditions/i/invasive-ductal-breast-cancer-idc.html

https://www.aafp.org/pubs/afp/issues/2021/0800/p171.html

https://www.cancer.gov/types/breast/patient/breast-treatment-pdq

https://www.mdanderson.org/cancerwise/invasive-ductal-carcinoma–6-things-to-know-about-this-common-breast-cancer.h00-159775656.html

https://www.breastcancer.org/types/metastatic/life-with-metastatic/tips-for-moving-forward

https://www.mayoclinic.org/healthy-lifestyle/womens-health/in-depth/breast-cancer-prevention/art-20044676

https://www.nationalbreastcancer.org/invasive-ductal-carcinoma/

https://www.lbbc.org/your-journey/living-with-metastatic-breast-cancer/living-well-with-metastatic-breast-cancer

https://www.premiersurgicalnetwork.com/blog/navigating-life-after-breast-cancer-diagnosis?utm_source=loclisting&utm_medium=Organic&utm_campaign=directory-appt&utm_content=PSNPA&rsiCampaignId=43255

https://www.bcrf.org/about-breast-cancer/breast-cancer-prevention-risk-reduction/

https://www.komen.org/blog/four-tips-for-living-well-with-metastatic-breast-cancer/

https://my.clevelandclinic.org/health/diseases/3986-breast-cancer

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What is the difference between a screening mammogram and a diagnostic mammogram?

A screening mammogram is a routine test for women without symptoms, designed to detect cancer early. A diagnostic mammogram is more detailed and is performed when you have symptoms like a lump or when a screening mammogram shows something abnormal. Diagnostic mammograms take additional images and views to investigate specific areas of concern more closely.[3]

Will I definitely need a biopsy if my mammogram shows something suspicious?

Not always. Your doctor might first order additional imaging tests like ultrasound or MRI to get a better look at the area. However, a biopsy is the only definitive way to know whether cancer is present. If imaging tests remain concerning, a biopsy will be necessary to examine the tissue under a microscope and determine if cancer cells are there.[3][13]

How long does it take to get biopsy results?

Waiting for biopsy results can be stressful. Typically, you can expect results within a few days to two weeks after your biopsy. The exact timing depends on the type of tests being performed on your tissue sample. Some tests, particularly those checking for hormone receptors and HER2 status, may take longer than basic examination for cancer cells. Your doctor will let you know when to expect your results.[14]

What does it mean if my cancer is hormone receptor-positive?

If your cancer is hormone receptor-positive, it means the cancer cells have receptors for estrogen, progesterone, or both. These hormones can help the cancer grow. This is actually somewhat positive news because it means hormone-blocking treatments are likely to be effective against your cancer. Hormone therapy can significantly reduce the risk of cancer returning.[10][15]

Do I need genetic testing after a breast cancer diagnosis?

Not everyone needs genetic testing, but it may be recommended if you were diagnosed at a young age, have a strong family history of breast or ovarian cancer, or if certain features of your cancer suggest a hereditary component. Genetic testing looks for inherited mutations like BRCA1 and BRCA2 that increase cancer risk. The results can help guide treatment decisions and inform family members about their own risks. Your doctor can help you decide whether genetic testing is appropriate for your situation.[16]

🎯 Key takeaways

  • Invasive breast carcinoma can often be detected before you notice symptoms through routine screening mammograms, highlighting the importance of following recommended screening guidelines
  • A combination of physical examination, imaging tests, and biopsy is typically needed to diagnose invasive breast carcinoma and understand its characteristics
  • Understanding your cancer’s receptor status—whether it has estrogen, progesterone, or HER2 receptors—is crucial because it determines which treatments are most likely to work for you
  • Most people who visit a breast clinic with concerning symptoms do not have cancer, so try not to panic before your diagnostic tests are complete
  • Clinical trials require specific diagnostic tests to determine eligibility, but participation offers access to cutting-edge treatments and very careful medical monitoring
  • Seeking a second opinion on your diagnosis or treatment plan is perfectly appropriate and can provide valuable additional perspective and confidence
  • Treatment outcomes for invasive breast carcinoma are continually improving thanks to advances in targeted therapies and earlier detection methods
  • The stage and grade of your cancer, along with your receptor status and overall health, all influence your individual prognosis and treatment plan